• CVS to stop stelling decongestants with phenylephrine

    CVS is voluntarily pulling from its shelves some common decongestants that contain an active ingredient FDA advisors have deemed ineffective at relieving congestion. 
  • How does your system manage rare disease patients? Becker's wants to hear.

    Fill out this short survey here and attend our annual meeting for free.
  • The rise of the chief pharmacy officer

    Pharmacy leaders have already cracked the code of hospital C-suites, but increasingly, they're entering executive positions across health systems. 
  • 1st study finds surge of weight loss drugs in health system

    A California health system has noted an "exponential" increase in patients using Wegovy, Mounjaro and other similar drugs for weight loss, according to a first-of-its-kind study.
  • Drugmaker to lay off 100+ after Biogen acquisition

    Reata Pharmaceuticals — a rare disease drugmaker recently acquired by Biogen — filed a WARN notice Oct. 9, alerting Texas officials of its plans to cut 113 positions. The layoffs will take effect Nov. 27. 
  • Pharmacy group urges US to block Optum-Amedisys deal

    Independent pharmacies and lawmakers are asking the federal government to probe UnitedHealth Group's proposed scoop of Amedisys, one of the largest home health and hospice care providers in the U.S.
  • Hospitals push back on CMS' drug shortage solution

    Hospital groups and healthcare think tanks are urging CMS to revise its proposal to address medication shortages, which have been persistent for decades and have struck multiple therapeutic areas in 2023. 
  • Pfizer sets list price for Paxlovid

    Pfizer has set the list price for a five-day course of Paxlovid at $1,390, according to an exclusive report from The Wall Street Journal. 
  • OptumRx opens integrated pharmacy in Arizona

    UnitedHealth Group's pharmacy care business OptumRx has opened a location in Mesa, Ariz., according to an Oct. 17 news release. 
  • Amazon begins prescription drone delivery in Texas

    Amazon's pharmacy customers in College Station, Texas, can now receive their prescriptions via drone delivery in under an hour, the company announced Oct. 18. 
  • HHS, Pfizer begin commercialization plans for Paxlovid

    Beginning in January, commercialization of Pfizer's Paxlovid antiviral medication will begin and could drive out-of-pocket prices north of $500 before insurance, according to CNN. 
  • The No. 1 priority among hospital pharmacy leaders

    Similar to many healthcare sectors, staffing shortages are compounding issues for hospital pharmacy leaders, according to a LinkedIn poll conducted by Becker's. 
  • 'Weight-loss drug wealth' shows up in charitable giving

    Nonprofit foundations aligned with Eli Lilly and Novo Nordisk are now among the largest in the world due to surging sales of drugs like Ozempic, Wegovy and Mounjaro, The Wall Street Journal reports. 
  • Alzheimer's drug researcher accused of 'egregious misconduct'

    Clinical trials for simufilam, an Alzheimer's drug made by Cassava Sciences, will continue even after one of its lead researchers has been accused of "long-standing and egregious misconduct in data management and record keeping," The New York Times reported Oct. 14.
  • Cuban's Cost Plus partners with Alto Pharmacy to expand access

    San Francisco-based Alto Pharmacy, will now accept Team Cuban Cards from Mark Cuban Cost Plus Drug Co., members, according to an Oct. 16 news release. 
  • Common antibiotic may be linked to neurological dysfunction, study says

    Researchers found very little difference in the outcomes of patients hospitalized with acute kidney injuries who received different antibiotics — cefepime or piperacillin-tazobactam — as treatment, according to the study published Oct. 14 in JAMA. 
  • Walgreens, CVS workers plan nationwide strike

    Pharmacy employees at Walgreens and CVS are in talks to organize nationwide walkouts and protests in late October, people familiar with the matter told CNBC.
  • Kaiser pharmacy workers continue 3-week strike, approve to double it

    As hundreds of pharmacy workers for Kaiser Permanente continue striking for up to three weeks in Oregon and Southwest Washington, their union approved another strike that could last almost four more weeks. 
  • Mounjaro helps patients lose 60+ pounds in study

    Mounjaro (tirzepatide), Eli Lilly's Type 2 diabetes drug, helped obese and overweight adults lose an average of 64 pounds after 84 weeks in a phase 3 trial. 
  • The cost of defending a pharmacist license grew 43% in 5 years

    Liability claims and incidents involving pharmacists have risen in individual cost, according to a new industry report. 
  • Paxlovid popularity dwindles

    When Pfizer's antiviral Paxlovid entered the U.S. market in December 2021, it quickly became the preferred COVID-19 drug. Nearly two years later, physicians aren't writing many prescriptions for the therapy once touted as a "breakthrough," NBC News reported. 

Featured Whitepapers

Featured Webinars